NEW YORK STOCK EXCHANGE, INC. · BMY
+0.47% · +$0.2700
Bristol-Myers Squibb Co

Bristol-Myers Squibb Co

Pharmaceuticals
$57.18
Veridion Score
BETAMEDIUM CONF · 4/6 factors
As of May 30, 4:47 PM EDT · BMY
Methodology
55/100
NEUTRAL

Composite intelligence score across six weighted factors. Higher score = stronger composite signal.

Score history: Coverage building
Institutional Flow · 90D
Corporate Insiders
SEC Form 4
48/ 100
-94K net shares (90d) · 82B / 75S
US Congress
Senate eFD + House STOCK Act
/ 100
no data
Wall Street Analysts
Sell-side consensus
63/ 100
6 SB · 9 B · 19 H · 2 S
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Insider · Congress · Wall Street flow
  • · Pro Chart event markers
  • · Score history + alerts
Confidence: MEDIUM · 4/6 factors with data · Computed May 30, 4:47 PM EDT · Refreshes hourly
Veridion Score History · 90D

Composite trend over time

LOADING HISTORY…
REFRESHES DAILY
AI Analysis
BETA

Why is BMY moving today?

Analyzing news articles + insider activity + analyst signals…
About Bristol-Myers Squibb Co
PHARMACEUTICAL PREPARATIONS
Founded
Listed
1952
Employees
33K
HQ
US

Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Open
$57.00
Previous close
$56.91
Day high
$57.33
Day low
$56.53
Market cap
$116.77B
IPO
1980-03-17
Country
US
Currency
USD
Data ledger
Quote and day range
As of May 29, 4:00 PM EDT
Source: Market data
Veridion Score
As of May 30, 4:47 PM EDT
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Loading quarterly statements…
Insider activity · 6M
Loading Form 4 filings…
Congress · 90D
Loading PTR filings…
Federal contracts

BMY contract awards, year to date.

Public federal awards linked to this ticker.

$3.1M
Refresh interval: 12hSource: Federal contract awards
Department of Veterans Affairs
$364.1K
BREYANZI CAR-T

BREYANZI CAR-T

May 16, 2026
Department of Veterans Affairs
$364.1K
BREYANZI CAR-T TRANSPLANT.

BREYANZI CAR-T TRANSPLANT.

May 10, 2026
Department of Veterans Affairs
$364.1K
BREYANZI CAT-T TRANSPLANT

BREYANZI CAT-T TRANSPLANT

May 10, 2026
Department of Veterans Affairs
$364.1K
BREYANZI CAR T-TRANSPLANT

BREYANZI CAR T-TRANSPLANT

Apr 28, 2026
Department of Veterans Affairs
$356.5K
MAVACAMTEN (CAMZYOS) AND POMALIDOMIDE (POLMALYST)

MAVACAMTEN (CAMZYOS) AND POMALIDOMIDE (POLMALYST)

Feb 16, 2026
Lobbying spend

BMY lobbying filings, year to date.

Registered lobbying filings matched to Bristol-Myers Squibb Co.

$2.8M
Refresh interval: 12hSource: LDA disclosure filings
Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Copyright/Patent/Trademark Trade (domestic/foreign)Medicare/MedicaidHealth Issues Medicare/Medicaid Trade (domestic/foreign) Pharmacy
Filing
$1.3M
BRISTOL-MYERS SQUIBB COMPANY

BRISTOL-MYERS SQUIBB COMPANY

Apr 20, 2026
Filing
$1.3M
BRISTOL-MYERS SQUIBB COMPANY

BRISTOL-MYERS SQUIBB COMPANY

Jan 20, 2026
Filing
$80.0K
BRISTOL-MYERS SQUIBB

THE MCMANUS GROUP

Apr 20, 2026
Latest news · BMY
Refresh interval: 5 minutes · Source: Market news insights
Loading articles…
Analyst ratings
Loading consensus…
Options · Live
Loading options chain…
Related tickers

Cross-references from this score page.

Apprentice · 1 rail
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.